{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:38:49Z","timestamp":1769128729285,"version":"3.49.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1142","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Jiangsu Provincial Medical Innovation Team","award":["NO.CXTDA2017009"],"award-info":[{"award-number":["NO.CXTDA2017009"]}]},{"name":"Jiangsu Province\u2019s 333 High-Level Talents Project","award":["BRA2017539"],"award-info":[{"award-number":["BRA2017539"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770327"],"award-info":[{"award-number":["81770327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873486"],"award-info":[{"award-number":["81873486"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province\u2019s Key Provincial Talents Program","award":["ZDRCA2016043"],"award-info":[{"award-number":["ZDRCA2016043"]}]},{"name":"Natural Scientific Fund of Jiangsu province","award":["BK20161226"],"award-info":[{"award-number":["BK20161226"]}]},{"name":"Jiangsu Provincial Medical Innovation Team","award":["NO.CXTDA2017009"],"award-info":[{"award-number":["NO.CXTDA2017009"]}]},{"name":"Jiangsu Province\u2019s 333 High-Level Talents Project","award":["BRA2017539"],"award-info":[{"award-number":["BRA2017539"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770327"],"award-info":[{"award-number":["81770327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873486"],"award-info":[{"award-number":["81873486"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province\u2019s Key Provincial Talents Program","award":["ZDRCA2016043"],"award-info":[{"award-number":["ZDRCA2016043"]}]},{"name":"Natural Scientific Fund of Jiangsu province","award":["BK20161226"],"award-info":[{"award-number":["BK20161226"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Trials studying iron administration in patients with chronic heart failure (CHF) and iron deficiency (ID) have sprung up these years but the results remain inconsistent. The aim of this meta-analysis was to comprehensively evaluate the efficacy and safety of iron therapy in patients with CHF and ID. A literature search was conducted across PubMed, Embase, Cochrane Library, OVID and Web of Science up to 31 July 2019 to search for randomised controlled trials (RCT) comparing iron therapy with placebo in CHF with ID, regardless of presence of anaemia. Published studies reporting data of any of the following outcomes were included: all-cause death, cardiovascular hospitalisation, adverse events, New York Heart Association (NYHA) functional class, left ventricular ejection fraction (LVEF), N-terminal pro b-type natriuretic peptide, peak oxygen consumption, 6\u2009min walking test (6MWT) distance and quality of life (QoL) parameters. 15 RCTs with a total of 1627 patients (911 in iron therapy and 716 in control) were included. Iron therapy was demonstrated to reduce the risk of cardiovascular hospitalisation (OR 0.35, 95%\u2009CI 0.12 to 0.99, p=0.049), but was ineffective in reducing all-cause death (OR 0.59, 95%\u2009CI 0.33 to 1.06, p=0.078) or cardiovascular death (OR 0.80, 95%\u2009CI 0.39 to 1.63, p=0.540). Iron therapy resulted in a reduction in NYHA class (mean difference (MD) \u22120.73, 95%\u2009CI \u22120.99 to \u22120.47, p&amp;lt;0.001), an increase in LVEF (MD +4.35, 95%\u2009CI 0.69 to 8.00, p=0.020), 6MWT distance (MD +35.44, 95%\u2009CI 11.55 to 59.33, p=0.004) and an improvement in QoL: EQ-5D score (MD +4.07, 95%\u2009CI 0.84 to 7.31, p=0.014); Minnesota Living With Heart Failure Questionnaire score (MD \u221219.47, 95%\u2009CI \u221223.36 to \u221215.59, p&amp;lt;0.001) and Patients Global Assessment (PGA) scale (MD 0.71, 95%\u2009CI 0.32 to 1.10, p&amp;lt;0.001). There was no significant difference in adverse events or serious adverse events between iron treatment group and control group. Iron therapy reduces cardiovascular hospitalisation in patients with CHF with ID, and additionally improves cardiac function, exercise capacity and QoL in patients with CHF with ID and anaemia, without an increase of adverse events.<\/jats:p>","DOI":"10.1136\/postgradmedj-2019-137342","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T21:20:49Z","timestamp":1598390449000},"page":"766-776","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and safety of iron therapy in patients with chronic heart failure and iron deficiency: a systematic review and meta-analysis based on 15 randomised controlled trials"],"prefix":"10.1093","volume":"96","author":[{"given":"Junyi","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First Affilisted Hospital of Soochow University , Suzhou, Jiangsu , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengda","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affilisted Hospital of Soochow University , Suzhou, Jiangsu , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affilisted Hospital of Soochow University , Suzhou, Jiangsu , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8577-9791","authenticated-orcid":false,"given":"Yafeng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affilisted Hospital of Soochow University , Suzhou, Jiangsu , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0735-1097(02)01854-5","article-title":"Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure","volume":"39","author":"Horwich","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ejhf.473","article-title":"Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials","volume":"18","author":"Jankowska","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2796.1989.tb01410.x","article-title":"Iron deficiency: does it matter?","volume":"226","author":"Dallman","year":"1989","journal-title":"J Intern Med"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3177\/jnsv.30.47","article-title":"Functional consequences of iron deficiency in human populations","volume":"30","author":"Scrimshaw","year":"1984","journal-title":"J Nutr Sci Vitaminol"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tcb.2006.12.003","article-title":"Y. & Richardson, D. R. Iron uptake and metabolism in the new millennium","volume":"17","author":"Dunn","year":"2007","journal-title":"Trends Cell Biol"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/ejhf.161","article-title":"Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis","volume":"16","author":"Yeo","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/ajcn\/79.3.437","article-title":"Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women","volume":"79","author":"Brownlie","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.amjmed.2019.02.018","article-title":"Iron supplementation improves cardiovascular outcomes in patients with heart failure","volume":"132","author":"Zhou","year":"2019","journal-title":"Am J Med"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/eurheartj\/ehx502.P2425","article-title":"P2425Effects of intravenous iron therapy on chemoreflex sensitivity and sleep disordered breathing in chronic heart failure","volume":"38","author":"Caravita","year":"2017","journal-title":"Eur Heart J"},{"key":"2023041707540276800_","first-page":"E33","article-title":"The effects of ferrous sulphate supplementation on left ventricular intrinsic function by global longitudinal strain in systolic heart failure patient with iron deficiency anaemia","volume":"19","author":"Sagita","year":"2017","journal-title":"Eur Heart J"},{"key":"2023041707540276800_","article-title":"in Congress of the European Society of Cardiology (ESC, 2017).","author":"Gentil"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ehf2.12250","article-title":"Single-Dose intravenous iron in Southeast Asian heart failure patients: a pilot randomized placebo-controlled study (PRACTICE-ASIA-HF)","volume":"5","author":"Yeo","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/CIRCULATIONAHA.118.038516","article-title":"Effect of iron Isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency","volume":"139","author":"Charles-Edwards","year":"2019","journal-title":"Circulation"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcms.2010.11.001","article-title":"Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias","volume":"39","author":"Knobloch","year":"2011","journal-title":"J Craniomaxillofac Surg"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City cardiomyopathy questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.amjcard.2016.02.018","article-title":"Relation of longitudinal changes in quality of life assessments to changes in functional capacity in patients with heart failure with and without anemia","volume":"117","author":"Cooper","year":"2016","journal-title":"Am J Cardiol"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.hlc.2014.12.161","article-title":"Changes in echocardiographic parameters in iron deficiency patients with heart failure and chronic kidney disease treated with intravenous iron","volume":"24","author":"Toblli","year":"2015","journal-title":"Heart Lung Circ"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.hlc.2016.06.254","article-title":"Early responses to intravenous iron therapy in patients with chronic heart failure and iron deficiency","volume":"25","author":"Wong","year":"2016","journal-title":"Heart, Lung and Circulation"},{"key":"2023041707540276800_","first-page":"OC18","article-title":"Long-Term effect of intravenous iron on overall survival and hospitalization in patients with heart failure with reduced ejection fraction, iron deficiency and mild renal impairment: an open-label 5-year follow up observation","volume":"11","author":"Toblli","year":"2017","journal-title":"Journal Of Clinical And Diagnostic Research"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia","volume":"168","author":"Beck-da-Silva","year":"2013","journal-title":"Int J Cardiol"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2016.04.018","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: an updated systematic review and meta-analysis","volume":"68","author":"Shepshelovich","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1681\/ASN.2006080856","article-title":"Clinical aspects of iron use in the anemia of kidney disease","volume":"18","author":"H\u00f6rl","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ejhf.236","article-title":"Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?","volume":"17","author":"McDonagh","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jcsm.12282","article-title":"Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure","volume":"9","author":"Tkaczyszyn","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2023041707540276800_","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1523-1755.2004.00819.x","article-title":"Parenteral iron therapy: beyond anaphylaxis","volume":"66","author":"Alam","year":"2004","journal-title":"Kidney Int"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/96\/1142\/766\/49934385\/postgradmedj-96-766.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/96\/1142\/766\/49934385\/postgradmedj-96-766.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T08:40:43Z","timestamp":1696581643000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/96\/1142\/766\/6959198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":36,"journal-issue":{"issue":"1142","published-online":{"date-parts":[[2020,8,25]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2019-137342","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,8,25]]}}}